They need 80% of the 145,000,000 shares which is 116,000,000. They currently have about 72% of the 145million or 105,000,000. Still 11,000,000 short.However, given the buying and the odd acceptance, they'll probably get it by the March deadline.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
